GlassScriptPhysician profile
Marc A Arnold
NPI 1912042839
$4,275.19
in general payments reported to CMS, 2019-2025
28 companies · $882 in 2025
The $882 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $241 · 2022: $923 · 2023: $1,137 · 2024: $1,092 · 2025: $882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,087 · Education: $24.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,086.74 |
| Education | $24.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $548.75 | 2022-2025 | Watchman Flx, Watchman, Cds - Mct/Cem Monitoring |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $368.49 | 2022-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $360.65 | 2021-2025 | Lokelma, Farxiga |
| Abbott Laboratories | $358.52 | 2021-2024 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $312.22 | 2023-2025 | |
| Impulse Dynamics (USA) INC. | $281.17 | 2022-2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $229.95 | 2022-2025 | Jardiance |
| Amgen INC. | $201.12 | 2022-2024 | Repatha |
| Atricure, INC. | $196.75 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $184.06 | 2021-2025 | Eliquis, Camzyos |
| Pfizer INC. | $172.19 | 2022-2025 | |
| Novo Nordisk INC | $154.38 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Edwards Lifesciences Corporation | $149.97 | 2023 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $144.52 | 2022 | |
| Scpharmaceuticals INC. | $97.16 | 2023-2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $80.47 | 2023-2025 | Verquvo |
| Cardiva Medical, INC. | $68.80 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Kestra Medical Technology Services, INC. | $59.23 | 2023-2025 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $50.02 | 2024-2025 | Onpattro |
| Abbvie INC. | $49.94 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $43.57 | 2023 | Arcalyst |
| Lilly USA, LLC | $41.11 | 2024-2025 | Zepbound, Mounjaro |
| Janssen Pharmaceuticals, INC | $34.04 | 2023 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $20.65 | 2024 | |
| Irhythm Technologies, INC. | $19.90 | 2023 | Zio Xt Patch |
| Axsome Therapeutics, INC. | $18.82 | 2025 | Auvelity |
| Electromed, INC. | $15.49 | 2025 | Smartvest |
| Philips North America LLC | $13.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.